MahERosenthalMTsuyukiRT. Study of Understanding Pharmacists’ Perspectives on Remuneration and Transition toward Chronic Disease Management (SUPPORT-CDM): results of an Alberta-wide survey of community pharmacists. Can Pharm J (Ott)2009:142:136-43.
2.
WubbenDPVivianEM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy2008:28:421-36.
3.
CollinsCLimoneBLScholleJMColemanCI. Effect of pharmacist intervention on glycemic control in diabetes. Diab Res Clin Pract2011:92:145-52.
4.
Al HamarnehYNCharroisTLewanczukRTsuyukiRT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open2013;3:e003154. DOI: 10.1136/bmjopen-2013-003154.
5.
SantschiVColosimoALChioleroA. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diab Care2012:35:2706-17.
6.
HarrisMI. Medical care for patients with diabetes: epidemiologic aspects. Ann Intern Med1996;124(1pt 2):117-22.
7.
KroonLAColemanLTKoda-KimbleMA. The management of type 2 diabetes mellitus: a call to action for pharmacists. US Pharmacist1997; May (suppl 1):1-18.
8.
CampbellK. DCCT opens new opportunities for pharmacists. California Pharmacist1993;Dec:26-7.
9.
ShiuJRSimpsonSHJohnsonJATsuyukiRT. Quantifying opportunities to affect diabetes management in the community. Can Pharm J (Ott)2006:139:37-8.